| Exclusion criteria
In vitro and preclinical studies, cohort studies, case series, case reports, retrospective studies and RCT or CCT with less than 10 patients/sites per group and studies not meeting all inclusion criteria.
| Screening and selection of studies
Publication records and titles identified by the electronic search and hand search were independently screened by two reviewers (FJS and AS), based on the inclusion criteria. No restrictions were applied neither for languages, years considered nor for publication status.
Discrepancies were solved by discussion including a third reviewer (RG). Cohen's Kappa-coefficient was used as a measure of agreement between the readers. Thereafter, full texts of the selected abstracts were obtained. Where full texts could not be obtained authors and editors of the respective journal were contacted. The two reviewers independently performed the whole screening process, i.e., from the MeSH and Emtree term search up to the full-text examination.
Then, articles that met the inclusion criteria were processed for data extraction.
| Data extraction and quality assessment
The inclusion criteria were applied for data extraction. The studies were classified according to study design and type of intervention. Then, outcomes were compiled in tables. All extracted data were double-checked, and any questions that came up during the screening and the data extraction were discussed within the authors to aim for consensus. Two reviewers (FJS and AS) independently evaluated the methodological quality of all included studies using the Cochrane Collaboration's tool for assessing risk of bias in randomized trials (Higgins et al., 2011) . All included studies were checked for the following criteria: (a) sequence generation (b) allocation concealment (c) blinding of participants and personnel (d) blinding of outcome assessment (e) incomplete outcome data (f) selective reporting (g) other bias. Any disagreement was discussed until consensus was achieved. Each study was classified into the following groups: low risk of bias if all quality criteria were judged as "present", moderate risk of bias if one or more key domains were "unclear", and high risk of bias if one or more key domains were not "present".
| RE SULTS

| Selection of studies
The literature search identified 8,975 potential references in Medline and 517 in Embase of which 54 were eligible after title and abstract screening (inter-reviewer agreement κ = 0.914 ± 0.059). Geurs et al., 2014; Mozzati, Gallesio, di Romana, Bergamasco, & Pol, 2014; Raghoebar et al., 2005) . Of the 59 full-text articles, 27 did not meet the inclusion criteria and were excluded ( Figure 1 ; Table 1 of excluded studies). The remaining 18 RCTs and 14 CCTs were discussed in the EAO consensus meeting. Studies dealing with third molar extractions were excluded (Table 1) . Consequently, 15 RCTs and seven CCTs were included for data extraction. The included studies were divided into subgroups, depending on the area of PRP application (Tables 2-4):
| Quality assessment of the included studies
Quality and risk assessment was independently conducted by two authors (FJS and AS) and are represented in Figures 2 and 3. Discrepancies were solved by discussion until reaching consensus. Included RCTs and CCTs were rated following the Cochrane collaboration's tool for assessing risk of bias. Two studies demonstrated low risk of bias for all but one criteria and the majority showed a moderate to high risk of bias. Most studies failed to provide a detailed report about both randomization and allocation concealment and other key domains increasing the risk of bias. Nine studies described the randomization process, 6 the allocation concealment in sufficient detail. One study was registered to an online database which allows for judgment of selective outcome bias. Adequate blinding of patients and personnel was stated in five trials, blinding of surgeons in four, and blinding of outcome assessors in nine trials. None of the studies provided an intention-to-treat analysis of their patients and only four studies described sample size calculations.
| Study design and evaluation period
Fifteen RCTs and seven CCTs were included. A total of six studies were RCTs where a split-mouth design was applied Bettega et al., 2009; Consolo et al., 2007; Mozzati et al., 2014; Schaaf, Streckbein, Lendeckel, Heidinger, Rehmann, et al., 2008; Torres et al., 2009 ) The remaining nine RCTs used a parallel group design. Of the CCTs, five were designed as split mouth Monov et al., 2005; Stenport et al., 2011; , two as parallel group studies . The follow-up period ranged considerably from 10 days to 30 months.
| Subject characteristics
All but one study included healthy subjects with no active inflammatory disease. The mean age varied from 18 to 80. The number of included patients lied between 10 and 80.
Smokers were included in eight, excluded in seven and not reported in seven studies.
| Data extraction
Included studies presented a high heterogeneity in regards to outcome measures, PRP preparation or study duration. Therefore, a meta-analysis was not feasible.
| Sinus floor elevation (totally 374 patients)
All included studies (12) applied PRP in combination with iliac bone (seven), autologous intraoral bone grafts (one), β-tricalcium phosphate (β-TCP; one), bovine bone graft (BBG) (Unilab Surgibone ® /one study) and deproteinized bovine bone mineral (DBBM, two). Table 2 depicts the outcome measures of included studies.
Iliac bone graft Consolo et al., 2007; Schaaf, Streckbein, Lendeckel, Heidinger, Rehmann, et al., 2008; Schaaf, Streckbein, Lendeckel, Heidinger, Gortz, et al., 2008; Stenport et al., 2011; : no statistical differences in resonance frequency analysis values for the posterior maxilla, but significant differences for the anterior maxilla F I G U R E 1 PRISMA flow diagram at abutment connection and at 1-year follow-up was reported by one study . Higher densitometric and trabecular bone values for time-periods up to 6 months were found in favor of PRP . Thor and coworkers showed superiority of bone formation after 3 months for the PRP group, which disappeared after 6 months, yet biopsies were not obtained from all patients . No additive effects of PRP were found in survival rate , augmentation height , marginal bone level changes , bone density Schaaf, Streckbein, Lendeckel, Heidinger, Rehmann, et al., 2008) , volume of both lamellar and woven bone , volume of new bone and angiogenesis (Stenport et al., 2011) .
Autologous intraoral bone grafts: In terms of bone height after grafting significant differences were found immediately and 6 months after surgery .
Bovine bone graft: there was only one study using BBG (Unilab Surgibone ® ) and no additional effects of PRP were found when looking at implant survival rates, ISQ values, soft tissue healing, and histological parameters such as residual amount of graft, or trabecular bone structure.
Deproteinized bovine bone mineral: two studies combined DBBM with PRP. One study using DBBM demonstrated that PRP was associated with significantly less pain and higher quality of life parameters post-surgery . The other study using DBBM showed that PRP significantly increased new bone formation ). However, histomorphometric analysis was only performed in five patients with a split-mouth design and the implant survival rate was not affected by PRP ).
| Alveolar ridge preservation (totally 145 patients)
One study evaluated the use of PRP for ridge preservation. A denser trabecular pattern, less pain sensation and better soft tissue healing (Alissa et al., 2010) were reported. Three studies used PRGF (Anitua et al., 2015; Farina et al., 2013; Mozzati et al., 2014) . for all assessed outcomes. Superior results for PRGF were described in diabetic patients: less pain during the first 14 days and a smaller residual socket volume during the first 7 days were observed in the test group . However, no differences in terms of mineral density and mineralization were described by Farina (Table 3a) .
| Alveolar ridge augmentation (totally 62 patients)
Only two studies were found, both of which showed better results with PRP. Ridge width at the marginal crest was higher in the PRP group as well as the percentage of vital bone .
PRP further enhanced the average gain of bone height and width and TA B L E 1 List of excluded full-text papers and reasons for exclusion following full-text screening 5,600 rpm/15 min 2,400 rpm/10 min + 10% thrombin + CaCl Histomorphometry -new bone formation (%): SS at 3 months (T: 22 ± 9 vs. C: 11 ± 3, p = 0.028) and NS at 6 months (T: 14 ± 7 vs. C: 13 ± 6, p > 0.05) -old bone (%): NS at 3 (T: 13 ± 7 C: 20 ± 11, p = 0.063) and 6 months (T: 19 ± 10 C: 23 ± 11, p > 0.05) reduced mesh exposure . Survival rates were similar for both groups , along with greater apical ridge width and alveolar height changes (Table 3b ).
| Implant placement (56 patients in three studies and one study that did not report the number of patients)
Four studies used PRP during implant placement. Only one study performed GBR . PRP enhancing bone formation was found in two studies Georgakopoulos et al., 2014) . This was associated with larger bone width, higher bone density and less marginal bone loss Georgakopoulos et al., 2014) . When looking at implant stability, data are scarce (from 40 patients) and pointing toward no differences (Kundu & Rathee, 2014; Monov et al., 2005) (Table 4) .
| D ISCUSS I ON
The present systematic review focused on RCT and CCT studies using PRP in all fields connected to implant dentistry including sinus floor augmentation, socket preservation, ridge augmentation or peri-implantitis. The aim was to evaluate the current knowledge with respect to the clinical indications of PRP on soft tissue healing and bone regeneration with respect to implant placement. Analysis of the selected publications revealed heterogeneity of results with a general lack of conclusive evidence, mainly because of being underpowered, and incomplete reporting of study design. Owing to the heterogeneity of the study design, the various outcome measures, and the slightly different method of preparing PRP, no meta-analysis could be performed-neither for bone formation and soft tissue healing nor for implant stability, osseointegration, and implant survival.
| Sinus floor elevation
A previous systematic review suggested that PRP might improve SFE outcome parameters (Bae, Kim, & Myung, 2011) . The present report is based on 12 clinical trials when grafting materials were combined with PRP. Results are conflicting. PRP increased bone formation and bone height in four studies Torres et al., 2009; Wiltfang et al., 2003) . These positive findings, however, should be interpreted with caution. For example, Kumar et al. described a greater bone height in the PRP group immediately after surgery but this difference disappeared at the 12-month follow-up. The positive outcome in favor of PRP up to 6 months could be explained by the surgical procedure per se rather than the use of PRP. Torres et al. reported more bone formation in the PRP group, however, the histological analysis included biopsies from only five patients and not from the whole sample. All other parameters, including implant survival and densitometry, were not significant. Similarly, Thor et al.
described higher bone formation in the PRP group at the 3-month follow-up, nonetheless, these differences disappeared after 6 months.
In line with these findings, other studies failed to find significant differences when using a variety of bone graft materials (autologous bone from the iliac crest, DBBM, BBG, β-TCP), different surgical approaches and variable residual bone heights before the intervention. In the majority of studies, residual graft size and graft resorption were found to be similar among the groups as well as implant survival rates Schaaf, Streckbein, Lendeckel, Heidinger, Rehmann, et al., 2008; Torres et al., 2009 ).
Another aspect that was evaluated in two studies was implant stability measured by ISQ values . While Cabbar et al. found no significant differences, Thor group. The latter study performed inlay grafts for SFE and onlay grafts for the anterior maxilla followed by implant placement. At 1-year follow-up, however, significant differences were detected only in the anterior maxilla . This should be interpreted with prudence, as it is questionable if this statistical difference suggests a clinical benefit of PRP. Furthermore, there is a lack of data based on the long-term outcomes by means of PRP.
In summary, inconclusive results are reported because of underpowered studies lacking hard endpoints. None of the studies included used PRP without a grafting material. Therefore, the effect of PRP alone on bone regeneration during SFE remains questionable.
| PRP and alveolar bone regeneration
Based on the growth factors contained in PRP, filling a post-extraction socket with PRP has the potential to improve bone regeneration and soft tissue healing. The ultimate goal is to enhance wound healing and facilitate implant placement in a prosthetically driven position.
It should be pointed out that the included studies applied PRP or PRGF. Even though both preparations showed beneficial results, caution should be taken when drawing a conclusion, as for PRP in extraction sockets only one study with a small patient number could be included, and for PRGF heterogenous results have been stated.
PRGF differs from PRP in that it is depleted of leukocytes.
Two studies (Anitua et al., 2015; Farina et al., 2013) reported on bone regeneration at extraction sockets using PRGF. In one study Further studies are required to establish the benefit of PRGF and PRP for this clinical indication.
Three studies (Alissa et al., 2010; Anitua et al., 2015; Mozzati et al., 2014) reported outcomes using a soft tissue healing index. PRP The lack of detailed data in both studies precludes a comprehensive comparison of the results. One noteworthy finding, however, was the absence of titanium mesh exposure in the PRP group compared to 28.5% in the control group . Overall, given the low number of studies and the different surgical approaches used, it is difficult to generate clinical recommendations.
F I G U R E 3 Quality assessment of the included studies: Risk of bias graph
| PRP and pain
Pain is an important patient-reported outcome measure and significantly determines the quality of patient's oral surgery experience (Coulthard, Patel, Bailey, & Armstrong, 2014) . Three studies included patientreported outcome measures, mainly using the Visual Analogue Scale.
However, the positive effect of PRP on postoperative pain was considered biased in two of three studies due to lack of blinding. All outcomes can be affected by lack of blinding as there is a special risk of bias with subjective outcomes such as pain (Wood et al., 2008) . Consequently, the present data must be interpreted with caution. Significantly less pain was reported in the PRP group for SFE and for alveolar ridge preservation (Alissa et al., 2010; Anitua et al., 2015) .
Del Fabbro et al. showed a significant difference in SFE only after 2 and 3 days. From the 4th day on, the significant difference disappeared, which is in line with the results from Alissa et al. who detected differences between the groups only until the 3rd day post-op while Anitua et al. observed less pain during the first 7 days in the PRGF group. In summary, owing to study design there is not enough evidence to support that PRP reduces pain after the surgical procedure.
Another aspect that should be considered is the postoperative swelling. Only one study assessed swelling after sinus lift elevation . Patients in the PRP group perceived less swelling during the first 4 days postoperatively. However, this parameter was measured using a self-administered questionnaire. As a result, more studies are warranted.
| Dental implants
With respect to PRP application during implant placement, only three RCTs and 1 CCT were included. Two studies assessed implant stability at different time-points with inconsistent results (Kundu & Rathee, 2014; Monov et al., 2005) . Only one study found significant
higher ISQ values in the PRP group at implant placement (Kundu & Rathee, 2014 ) that were no longer present after 1 and 3 months. PRP was found to provide a higher bone width, higher bone density, and less marginal bone resorption at 9 and 12 months . Despite these positive findings, it remains unclear if PRP predictably improves osseointegration, implant success and survival.
| Peri-implantitis
Regarding the application of PRP during peri-implantitis treatment, no RCT or CCT could be found in the present systematic review.
Thus, it remains unknown what effect PRP may play in the treatment of peri-implantitis, precluding any clinical recommendation.
| CON CLUS ION
On the basis of studies with limited statistical power, the present review demonstrated that (i) for SFE PRP/PRGF combined with grafting materials may transiently enhance bone formation, (ii) for alveolar ridge preservation PRP/PRGF might improve bone regeneration and wound healing, (iii) PRP might reduce postoperative pain and swelling, and finally (iv) for implant placement and peri-implantitis defects there is a lack of adequate studies on PRP.
| FUTURE D IREC TI ON
The studies included in the present review mainly focused on surro- 
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